Project Number 1U01AG047059-01 Agency/Funding Organization NIA Funding Year 2014 View Full Project Details for LEAD OPTIMIZATION OF RECEPTOR ANTAGONIST CT0093 FOR DISEASE-MODIFYING ALZHEIMER'S Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator CATALANO, SUSAN M Principal Investigator First Name SUSAN Principal Investigator Last Name CATALANO Awardee Organization Cognition Therapeutics, Inc. Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-13-014: Alzheimer's Disease Therapeutics Program (U01) FY Overall Cost $699,915 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
